Objectives This study aimed to systematically review the use of cost-effectiveness (CE)
threshold for evaluating pharmacological interventions in Greece. Methods A systematic …

Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

Introdução e objetivos Os novos anticoagulantes orais são opções emergentes para a
prevenção e tratamento das doenças tromboembólicas. São cada vez mais usados na …

The introduction of non-vitamin K antagonist oral anticoagulants (NOACs) into clinical
practice represented a major change in the treatment of non-valvular atrial fibrillation …

Background Atrial fibrillation (AF) is a severe epidemiological and public health concern
among the elderly population worldwide, with substantial economic and social burdens …

Introdução e objetivos Os novos anticoagulantes orais são opções emergentes para a
prevenção e tratamento das doenças tromboembólicas. São cada vez mais usados na …

K antagonists, known as coumarins, to protect patients against dangerous thrombosis. New
anticoagulants have been developed recently and are likely to predominate in the coming …

The relevant cost-effectiveness study reports economic terms in the currency units of each
country at a certain time unit, so that currency conversion is needed for the standardization …

Atrial fibrillation (AF) is associated with a five-fold increase in the risk of thromboembolic
events (stroke/systemic embolism). When initiated in individuals at risk of a thromboembolic …

Objectives: As model-based economic evaluations (MBEEs) are widely used to make
decisions in the context of policy, it is imperative that they represent clinical practice. Here …